Alpine Global Management, LLC Viking Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.0 - $4.88 $80,325 - $130,662	-26,775 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $123,164 - $179,928	26,775 New	26,775 $123,000
Q4 2019 Jan 16, 2020	SELL	$6.38 - $8.73 $159,500 - $218,250	-25,000 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$9.7 - $19.65 $242,499 - $491,249	25,000 New	25,000 $436,000
Q2 2018 Aug 15, 2018	SELL	$3.88 - $12.74 $155,200 - $509,600	-40,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.74 - $4.34 $69,600 - $173,600	40,000	40,000 $162,000

473

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.95B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.